Results 311 to 320 of about 2,726,604 (341)
Some of the next articles are maybe not open access.
Cardiovascular disease prevention
Primary Care: Clinics in Office Practice, 2002In this chapter, we have reviewed many of the steps necessary for effective CHD risk reduction. The first step in the office setting is to assess the individual CHD risk. This combines the evaluation of current CHD or a "secondary risk equivalent" with the counting of risk factors and in many cases, the absolute risk calculation.
Jon G, Keevil +2 more
openaire +2 more sources
Cardiovascular Disease Posttransplant
Seminars in Nephrology, 2007Renal transplantation is currently the preferred treatment modality for virtually all suitable candidates with end-stage renal disease. Compared with dialysis, kidney transplantation improves both patient survival and quality of life. Nonetheless, posttransplant cardiac complications are associated with increased morbidity and mortality after renal ...
Phuong-Thu T, Pham +2 more
openaire +2 more sources
Predicting cardiovascular disease
BMJ, 2016An over-abundance of risk models offering few real benefits to patients Emerging as a leading cause of death in the early 20th century and peaking in incidence in the 1960s, cardiovascular disease (CVD) remains a major global threat despite a progressively reducing incidence and case fatality for myocardial infarction and stroke.
openaire +2 more sources
Acquired Cardiovascular Disease
Veterinary Clinics of North America: Equine Practice, 1985This article reviews the etiology, clinical findings, and significance of diseases of the heart valves, myocardium, pericardium, and great vessels of the horse. Each valve is considered separately from the point of view of murmur production. In addition, the role of the cardiovascular system in the etiology of sudden and unexpected death is considered.
openaire +2 more sources
Platelets and cardiovascular disease
European Journal of Cardiovascular Nursing, 2002Platelets play an important, but often under-recognized role in cardiovascular disease. For example, the normal response of the platelet can be altered, either by increased pro-aggregatory stimuli or by diminished anti-aggregatory substances to produce conditions of increased platelet activation/aggregation and occur in active cardiovascular disease ...
Scott, Willoughby +2 more
openaire +2 more sources
Environmental Cardiovascular Disease
Cardiovascular Toxicology, 2005The last decade has seen a remarkable growth in the evidence establishing exposure to environmental agents as a risk factor for cardiovascular disease (CVD). Most of this has come from research linking exposure to ambient particulate matter with CVD, although more recent evidence suggests that the ozone might also be contributing factor.
openaire +2 more sources
2015
Cardiovascular disease (CVD) is the first cause of mortality and morbidity worldwide. It is responsible for 30 % of all deaths, so that more people die annually from CVD than from any other cause, and 10 % of global burden disease. Currently, the vast majority of deaths and disabilities due to CVD take place in low- and middle-income countries.
D'ANDREA, ELVIRA +2 more
openaire +1 more source
Cardiovascular disease (CVD) is the first cause of mortality and morbidity worldwide. It is responsible for 30 % of all deaths, so that more people die annually from CVD than from any other cause, and 10 % of global burden disease. Currently, the vast majority of deaths and disabilities due to CVD take place in low- and middle-income countries.
D'ANDREA, ELVIRA +2 more
openaire +1 more source
Leukotrienes in Cardiovascular Diseases
American Journal of Respiratory and Critical Care Medicine, 2000Cysteinyl-leukotrienes (cys-LTs, LTC4, LTD4,and LTE4) are potent lipid mediators, resulting from the oxidative metabolism of arachidonic acid through the 5-lipoxygenase (5-LO) pathway. They are able to affect all major components of the cardiovascular system: they can constrict small and large vessels, modify cardiac and coronary functions, influence ...
G. Folco +5 more
openaire +3 more sources
Hyperlipidaemia and cardiovascular disease
Current Opinion in Lipidology, 1998Abbreviations Apo: apolipoprotein; CAC: coronary artery calcium; CETP: cholesteryl ester transfer protein; CHD: coronary heart disease; HDL(c): high-density lipoprotein (cholesterol); IMT: intima-media thickness; LDL(c): low-density lipoprotein (cholesterol).Lipoprotein levels remain the primary ...
openaire +5 more sources